MDNews - Lower Hudson/Bronx

November 2013

Issue link: https://viewer.e-digitaledition.com/i/205083

Contents of this Issue

Navigation

Page 6 of 35

This list represents an advanced degree of capability for a community hospital. Dr. Ginsburg attributes this versatility to the wide range of medical talent Good Samaritan has attracted. "We have a strong pulmonary medicine team," he says. "We also have excellent gastroenterology, cardiology, anesthesiology, critical care medicine, nursing, radiology and oncology partners. Everyone works together for our patients. We bring in experts from multiple disciplines so we can effectively care for our patients through shared decision-making." While capabilities are numerous, Dr. Ginsburg notes that patients most Dr. Ginsburg performs a phrenic nerve pacemaker implantation on a 13-year-old Palestinian girl in Jerusalem. "It is rewarding to work in an environment where compassionate, quality care and high ethical standards are valued. That is the heart of what we do at Good Samaritan." — mark Ginsburg, mD, Chief of thoracic Surgery at Good Samaritan Regional medical Center frequently present with cancerous or precancerous conditions of the esophagus and with lung cancer and related conditions. At Good Samaritan, physicians offer these patients advanced care that can improve their quality of living, extend their lives and, in some cases, cure their conditions. i n n ovative eso phaG e al C ar e BâRRx MeDICAl'S HAlo System uses advanced radiofrequency ablation technology to treat patients with Barrett's Treatment for esophageal Conditions Providers at Good Samaritan Regional Medical Center treat many conditions related to esophageal health, including gastric reflux, Barrett's esophagus and esophageal cancer. Resulting from changes in the epithelial layer of the esophagus caused by acid reflux, Barrett's esophagus has the potential to progress to cancer. Radiofrequency ablation (RFA) therapy is a recognized method of treating both esophageal cancer and precancerous conditions of the esophageal lining. Often, RFA treatment of Barrett's esophagus results in almost complete success rates — better than 98 percent, sustained at least five years. "We perform minimally invasive reflux surgery, including Bârrx, which is radiofrequency ablation of Barrett's esophagus," Dr. Ginsburg says. "Generally, candidates include patients who are being monitored for reflux disease as well as those who have evidence of progressive Barrett's." According to Dr. Ginsburg, Barrett's esophagus typically afflicts the lower third of the esophagus. He finds RFA treatments to be curative after three sessions. "Patient response is very good," Dr. Ginsburg says. "This is a safe procedure with limited side effects, and by eliminating a premalignant condition, we can typically eliminate the risk of this cancer for these patients." Minimally Invasive Surgery for Resection of lung Cancers For cases in which patients already have lung cancer, multispecialty collaboration and minimally invasive techniques help physicians provide the best possible outcomes. "A vast majority of our thoracic surgery patients suffer from lung cancers," esophagus. Using a balloon catheter approach, a physician is able to remove Barrett's epithelium in very minimal segments with limited discomfort to the patient. the haLO ablation catheter uses heat to treat sections as small as 3 centimeters in circumference and between 500 and 1,000 microns in depth. With energy released in bursts of one second or less, the technology allows for controlled ablation that focuses on damaged tissue and limits trauma to patients. the physician has the ability to view the ablated areas endoscopically before and after the procedure, removing more tissue if necessary. new epithelial tissue grows in eight to 12 weeks, and most patients' Barrett's esophagus is completely cured. Dr. Ginsburg says. "We take a multidisciplinary approach to these cases." In the best-case scenario, radiologists detect lung cancers early, using low-dose CT scans. At Good Samaritan, these scans are open to patients with a history of smoking who are older than 50, or to those with a history of lung cancer. "Multiple studies show early detection of lung cancer improves the opportunity for a cure," Dr. Ginsburg says. "The cure rates for early-stage lung cancers are in excess of 90 percent. Therefore, we want to find these cancers as soon as possible." Surgically, physicians treat early-stage lung cancer with minimally invasive techniques, which involve a limited hospital stay. Even major resections are performed minimally invasively at Good Samaritan, Dr. Ginsburg says. Patients who have had lung surgery even recently may recall traumatic, ribsplitting procedures followed by lengthy MDNeWS.CoM ■ MD News Lower Hudson/Bronx |7

Articles in this issue

Archives of this issue

view archives of MDNews - Lower Hudson/Bronx - November 2013